VEGFA and neoplasm: To vertify our hypothesis that the loss of angiogenic factors plays an important role in tumor shrinkage in angiogenesis-driven tumor, sunitinib malate, which is a multiple tyrosine kinase inhibitor with effects including VEGF inhibition, was also administered in HOXB9 overexpressed tumor.